Singapore markets open in 1 hour 3 minutes

Coherus BioSciences, Inc. (CHRS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.65+0.17 (+2.00%)
At close: 04:00PM EST
8.48 -0.17 (-1.97%)
After hours: 05:00PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
Total revenue
239,061
326,551
475,824
356,071
Cost of revenue
67,985
57,591
37,667
17,078
Gross profit
171,076
268,960
438,157
338,993
Operating expenses
Research development
221,098
363,105
142,759
94,188
Selling general and administrative
194,912
169,713
139,079
137,037
Total operating expenses
416,010
532,818
281,838
231,225
Operating income or loss
-244,934
-263,858
156,319
107,768
Interest expense
28,882
22,959
21,166
17,601
Total other income/expenses net
-4,793
-283
554
2,608
Income before tax
-278,609
-287,100
135,707
92,775
Income tax expense
0
0
3,463
2,942
Income from continuing operations
-278,609
-287,100
132,244
89,833
Net income
-278,609
-287,100
132,244
89,833
Net income available to common shareholders
-278,609
-287,100
132,244
89,833
Basic EPS
-
-3.81
1.85
1.29
Diluted EPS
-
-3.81
1.62
1.23
Basic average shares
-
75,450
71,412
69,680
Diluted average shares
-
75,450
83,492
73,186
EBITDA
-
-260,687
159,761
113,635